Johnson & Johnson Vision Advocates on Behalf of Patients at FTC Public Workshop

Company emphasizes the importance of balancing policies that promote eye health alongside patient access and encouraging competition in the marketplace

News provided by

Johnson & Johnson Vision Care, Inc.

Mar 07, 2018, 05:44 ET

WASHINGTON, March 7, 2018 /PRNewswire/ -- Today, Peter Menziuso and Carol Lakkis, BScOptom, Ph.D., represented Johnson & Johnson Vision alongside fellow eye health advocates in Washington, D.C. to underscore the company's commitment to eye health and patient safety during the Federal Trade Commission's (FTC) public workshop.

Peter Menziuso and Dr. Carol Lakkis represented Johnson & Johnson Vision in the FTC workshop, "The Contact Lens Rule and Evolving Contact Lens Marketplace," on March 7 in Washington, D.C.

The workshop was held as part of the FTC's scheduled, 10-year review of the Contact Lens Rule and served as an opportunity for key stakeholders to share their feedback on how proposed changes may impact the patient-doctor relationship and consumers' access to innovative contact lenses—both now and in the future.

During the workshop, Mr. Menziuso, President, North America and Dr. Lakkis, Clinical Research Fellow, both of Johnson & Johnson Vision Care, Inc., underscored the benefits of a robust contact lens marketplace for consumers that promotes a positive patient experience while minimizing health-related risks.

"Three things are critical to ensuring a healthy eye health community – both now and in the future," said Mr. Menziuso. "First, is continuing to promote the importance of the doctor-patient relationship and regular, comprehensive eye exams. Next, is making sure patients receive the exact contact lenses as prescribed, regardless of where they choose to purchase. And lastly, we believe that contact lens wearers deserve care consistent with the high standard of care they receive in their eye doctor's office, regardless of where or how they receive it."

As the global market leader in contact lenses, Johnson & Johnson Vision is dedicated to advocating on behalf of initiatives that place the eye health and safety of the people who rely on our products first, at every step—passionately pursuing new technologies that meet high quality standards and improving and restoring sight for patients worldwide.

Mr. Menziuso and Dr. Lakkis represent Johnson & Johnson Vision through its operating company, Johnson & Johnson Vision Care, Inc.

To learn more about our commitment to eye health and vision safety, please visit https://jnjvisioncareinfo.com/.

Johnson & Johnson Vision
Johnson & Johnson Vision, through its operating companies, is committed to improving and restoring sight for patients worldwide. Since debuting the world's first disposable soft contact lens in 1987, Johnson & Johnson Vision Care, Inc. has been helping patients see better through their world-leading ACUVUE^® Brand Contact Lenses portfolio. In 2017, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 10,000 employees worldwide.

ACUVUE^® is a registered trademark of Johnson & Johnson Vision Care, Inc.

SOURCE Johnson & Johnson Vision Care, Inc.